{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:52:43Z","timestamp":1777344763297,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/igc.0b013e31825104f4","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T02:35:49Z","timestamp":1335839749000},"page":"786-791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of Chemotherapy-Induced Anemia in Ovarian Cancer Patients"],"prefix":"10.1016","volume":"22","author":[{"given":"Rodney P.","family":"Rocconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Blaize","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janeen","family":"Arbuckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri","family":"Bevis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M.","family":"Estes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddie","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Finan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31825104f4_bb0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1634\/theoncologist.5-5-353","article-title":"Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition","volume":"5","author":"Curt","year":"2000","journal-title":"Oncologist."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ctrv.2004.04.005","article-title":"Treatment of cancer-related anemia with epoetin alfa: a review","volume":"30","author":"Ferrario","year":"2004","journal-title":"Cancer Treat Rev."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ygyno.2005.11.027","article-title":"Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies","volume":"101","author":"Case","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3816\/SCT.2004.n.023","article-title":"Weekly administration of epoetin alfa improves cognition and quality of life in patients with breast cancer receiving chemotherapy","volume":"2","author":"Chang","year":"2004","journal-title":"Support Cancer Ther."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1008296622469","article-title":"Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study","volume":"9","author":"Oberhoff","year":"1998","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0030","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.clinthera.2009.11.020","article-title":"Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000Y2007","volume":"31","author":"Wu","year":"2009","journal-title":"Clin Ther."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0035","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2146\/ajhp080214","article-title":"Use of erythropoietin-stimulating agents in breast cancer patients: a risk review","volume":"66","author":"Crouch","year":"2009","journal-title":"Am J Health Syst Pharm."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0040","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/sj.bjc.6600247","article-title":"The level of haemoglobin in anaemic cancer patients correlates positively with quality of life","volume":"86","author":"Lind","year":"2002","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0045","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2141.2003.04448.x","article-title":"Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study","volume":"122","author":"Hedenus","year":"2003","journal-title":"Br J Haematol."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0055","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","article-title":"Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study","volume":"23","author":"Leyland-Jones","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0060","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.2006.07.1514","article-title":"Randomized, double-blind, placebo-controlled trial of erythropoietin in nonYsmall-cell lung cancer with disease-related anemia","volume":"25","author":"Wright","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0065","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djj189","article-title":"Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients","volume":"98","author":"Bohlius","year":"2006","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0070","first-page":"CD003407","article-title":"Erythropoietin or darbepoetin for patients with cancer","volume":"3","author":"Bohlius","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0075","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/93.16.1204","article-title":"Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials","volume":"93","author":"Seidenfeld","year":"2001","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0080","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.299.8.914","article-title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia","volume":"299","author":"Bennett","year":"2008","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0085","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1503\/cmaj.090470","article-title":"Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis","volume":"180","author":"Tonelli","year":"2009","journal-title":"CMAJ."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0090","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","article-title":"Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials","volume":"373","author":"Bohlius","year":"2009","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0095","unstructured":"Release EP. Available at: www.emea.europa.eu\/pdfs\/human\/ press\/pr\/33396308en.pdf. Accessed October 2010."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0100","unstructured":"Release FP. Available at: www.fda.gov\/medwatch\/safety\/2008\/ ESA_DHCP_Aug2008.pdf. Accessed October 2010."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1200\/JCO.2007.14.3396","article-title":"Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology\/American Society of Hematology clinical practice guideline update","volume":"26","author":"Rizzo","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31825104f4_bb0110","author":"National Comprehensive Cancer Network (NCCN) Guidelines"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24088133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24088133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:18:11Z","timestamp":1753233491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24088133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1048891X24088133"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31825104f4","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Chemotherapy-Induced Anemia in Ovarian Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31825104f4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}